The next board meeting for Eton Pharma Inc is on 19 Mar 2026 for the purpose of Eton Pharmaceuticals Inc Fourth Quarter Earnings Result for 2025See details
Eton Pharma Inc has a share price target of US$ 31, revenue growth forecast of 103.2%, and profit growth estimate of 14.9% for FY25, based on top 3 analyst calls.